1. Market Research
  2. > Biotechnology Market Trends
  3. > Biological Therapy

Biological Therapy Industry: Top Market Reports

  • Currently 5/5 Stars.
  • 1
  • 2
  • 3
  • 4
  • 5
1 vote

Global Biological Therapy Industry

The world biologics industry was worth almost $150 billion in 2010, according to research from BCC Research. The market is expected to record yearly growth of around 10% to reach almost $240 billion by 2015.

Market growth is fuelled by interest in biosimilars, the need to elaborate a superior drug pipeline, a move toward cost-reducing manufacturing technologies and appealing targets against challenging diseases.

Key Market Segments

The global gene therapy market is benefiting from increasing interest in the development of disease treatment. RNCOS notes that this market holds strong development potential as progress in the field of gene therapy facilitates research into the pathogenesis of diseases. This involves a move from research laboratories to clinical trials, which leads to greater potential for the biotechnology sector. Gene therapy market expansion is expected to be very strong over the coming years, fuelled by interest from biopharma companies focused on the area. Companies are expected to elaborate therapies for disease through on-site research and grow acquired therapies into commercial forms.

Gene therapy will prove vital to the medical industry to provide a disease-specific approach to developing treatments. The therapeutic applications of gene therapy are expanding to encompass areas like acquired diseases, including immunodeficiency syndromes. Growth is strong in the US, the EU, China, Japan and Canada. Cancer treatment is expected to represent the fastest-growing segment, followed by infectious diseases such as AIDS.

The global RNA Interference (RNAi) industry is expected to record 28% yearly growth for the five-year period ending 2015, reports RNCOS. Market growth will be fuelled by greater use of the expertise for functional genomics research, necessary for target validation, drug discovery and drug development. 

The worldwide market for cancer therapiesis expected to reach $225 billion by 2017, according to research from Global Industry Analysts. Market expansion will be fuelled by increasing numbers of cancer patients, adoption of new drugs and growing existing drugs. Market growth will also be driven by greater adoption of high-priced biologic therapies in cancer treatment. Medical treatment of cancer includes therapies such as chemotherapy, radiotherapy and gene therapy. The majority of cancer therapies are elaborated using hormones and cytokines, colony stimulating factors, monoclonal antibodies oncolytic viruses, cancer vaccines, antisense oligonucleotides and other approaches.

Leading companies in the sector include Takeda Pharmaceutical Company, GlaxoSmithKline, Eli Lilly, Amgen, Hoffmann-La Roche, Janssen Biotech, Sanofi-Aventis, AstraZeneca, Celgene Corporation, Novartis, Genentech and Bristol-Myers Squibb.

Regional Market Share

The US stem cell market is expected to record yearly growth of 45% between 2011 and 2013, reports RNCOS. The market has recorded strong growth over the past few years with massive investment despite the economic recession. Stem cell technologies and products are giving rise to breakthroughs in the treatment of diseases.

Read more »

Share

You might be interested in these related markets:

24/7 Customer Support

Talk to Sam

+33 4 37 65 17 06

1-10 of about 1200 reports

Global Biological Therapy Industry

  • January 2017
    21 pages
  • Health Services  

    Hospital  

  • Europe  

    World  

    United States  

View report >

Biological Therapy Industry in the US and the Netherlands

  • July 2017
    19 pages
  • Biological Ther...  

    Cytokine  

  • United States  

    Netherlands  

View report >

Biological Therapy Industry in Europe

  • August 2017
    15 pages
  • Biological Ther...  

  • Europe  

View report >

Biological Therapy Industry in Asia and the US

  • January 2016
    9 pages
  • Biological Ther...  

    Cell Therapy  

  • Asia  

    United States  

View report >

Biological Therapy Industry in Germany

  • March 2016
    14 pages
  • Biological Ther...  

  • Germany  

View report >

Biological Therapy Industry in the UK

  • April 2017
    10 pages
  • Biological Ther...  

    Cytokine  

  • United Kingdom  

View report >

Biological Therapy Industry in China

  • January 2017
    11 pages
  • Motor Vehicle  

  • China  

View report >

Biological Therapy Statistics in the Netherlands

  • April 2017
    17 pages
  • Biological Ther...  

  • Netherlands  

View report >

Search in Biological Therapy Industry (About 1200 reports)
Parent industry: Biotechnology
Related industries: Biomaterial, Biopharmaceutical, Genetically Modified Organism, Genomics

About 500 reports

Purchase Reports From Reputable Market Research Publishers
(From € 1125 - € 6545)

Biologics Outsourcing Global Market - Forecast to 2025

  • € 6545
  • Industry report
  • August 2017
  • by IQ4I Research & Consultancy Pvt. Ltd

The biologics outsourcing global market is expected to grow at double digit CAGR to reach $70.3 billion by 2025. Biologics are therapeutic entities composed of sugars, proteins, or nucleic acids made from ...

Cell Expansion Market - Global Industry Analysis, Size, ...

June 2017 € 5268

Collagen & Gelatin Market For Regenerative Medicine (by ...

August 2017 € 5045

Biobanking Market By Product And Service(equipment, Con ...

August 2017 € 5045

Biologics Safety Testing Market By Product, Test, Appli ...

July 2017 € 5045

Cell-based Assays Market By Product (reagents, Assay Ki ...

July 2017 € 5045

Radiotherapy Market By Type, Internal & Systemic, Produ ...

June 2017 € 5045

Single-cell Analysis Market By Product, Cell Type, Tech ...

June 2017 € 5045

Induced Pluripotent Stem Cells: Global Markets

June 2017 € 4825

Global Markets For Media, Sera And Reagents In Biotechn ...

June 2017 € 4825

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.